IOVANCE BIOTHERAPEUTICS INC (1IOVA.MI) Stock Analyst Earnings Estimates
BIT:1IOVA - Euronext Milan - US4622601007 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.189M | 164.07M 13,698.99% | 306.19M 86.62% | 517.87M 69.13% | 727.28M 40.44% | 894.62M 23.01% | 1.104B 23.40% | 1.268B 14.86% | 1.448B 14.20% | 1.64B 13.26% | ||
| EBITDA YoY % growth | -389.57M -14.72% | -427.432M -9.72% | -344.272M 19.46% | -358.442M -4.12% | -225.708M 37.03% | -183.596M 18.66% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -398.88M -16.39% | -460.559M -15.46% | -387.878M 15.78% | -377.457M 2.69% | -259.583M 31.23% | -108.073M 58.37% | 21.046M 119.47% | -2.137M -110.15% | -16.106M -653.70% | 805.8K 105.00% | 35.455M 4,299.98% | |
| Operating Margin | N/A | -38,734.99% | -236.41% | -123.28% | -50.13% | -14.86% | 2.35% | -0.19% | -1.27% | 0.06% | 2.16% | |
| EPS YoY % growth | -2.48 -11.71% | -1.88 24.19% | -1.30 30.85% | -1.16 11.13% | -0.77 33.75% | -0.22 71.35% | -0.05 75.21% | 0.51 1,038.09% | 0.77 50.00% | 0.93 21.33% | 1.03 10.44% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.27 2.50% | -0.24 9.09% | -0.21 41.52% |
| Revenue Q2Q % growth | 83.036M 41.81% | 97.993M 32.97% | 88.607M 79.64% |
| EBITDA Q2Q % growth | -95.829M -67.69% | -90.214M -153.62% | N/A |
| EBIT Q2Q % growth | -86.342M 3.06% | -78.223M 1.20% | -72.127M 40.50% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.33 2.94% | -0.29 | -0.04 | -13.70% |
| Q1 2025 Q2Q % growth | -0.36 14.29% | -0.24 | -0.12 | -47.45% |
| Q4 2024 Q2Q % growth | -0.26 42.22% | -0.27 | 0.01 | 4.58% |
| Q3 2024 Q2Q % growth | -0.28 39.13% | -0.31 | 0.03 | 8.26% |
| Q2 2024 Q2Q % growth | -0.34 27.66% | -0.36 | 0.02 | 5.66% |
| Q1 2024 Q2Q % growth | -0.42 16.00% | -0.43 | 0.01 | 2.54% |
| Q4 2023 Q2Q % growth | -0.45 29.69% | -0.44 | -0.01 | -2.23% |
| Q3 2023 Q2Q % growth | -0.46 26.98% | -0.46 | 0.00 | 0.73% |
| Q2 2023 Q2Q % growth | -0.47 25.40% | -0.81 | 0.34 | 42.15% |
| Q1 2023 Q2Q % growth | -0.50 13.79% | -0.76 | 0.26 | 34.19% |
| Q4 2022 Q2Q % growth | -0.64 -1.59% | -0.65 | 0.01 | 1.52% |
| Q3 2022 Q2Q % growth | -0.63 -14.55% | -0.65 | 0.02 | 3.17% |
| Q2 2022 Q2Q % growth | -0.63 -18.87% | -0.62 | -0.01 | -1.85% |
| Q1 2022 Q2Q % growth | -0.58 -13.73% | -0.65 | 0.07 | 10.65% |
| Q4 2021 Q2Q % growth | -0.63 -34.04% | -0.57 | -0.06 | -10.72% |
| Q3 2021 Q2Q % growth | -0.55 -37.50% | -0.54 | -0.01 | -2.01% |
| Q2 2021 Q2Q % growth | -0.53 -12.77% | -0.52 | -0.01 | -1.46% |
| Q1 2021 Q2Q % growth | -0.51 7.27% | -0.50 | -0.01 | -2.79% |
| Q4 2020 Q2Q % growth | -0.47 6.00% | -0.45 | -0.02 | -4.13% |
| Q3 2020 Q2Q % growth | -0.40 | -0.47 | 0.07 | 14.90% |
| Q2 2020 Q2Q % growth | -0.47 -23.68% | -0.54 | 0.07 | 12.37% |
| Q1 2020 Q2Q % growth | -0.55 -83.33% | -0.52 | -0.03 | -5.90% |
| Q4 2019 Q2Q % growth | -0.50 | -0.42 | -0.08 | -18.12% |
| Q3 2019 Q2Q % growth | -0.40 | -0.40 | 0.00 | 0.58% |
| Q2 2019 Q2Q % growth | -0.38 | -0.30 | -0.08 | -27.98% |
| Q1 2019 Q2Q % growth | -0.30 | -0.29 | -0.01 | -3.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 59.95M 92.73% | 71.188M | -11.238M | -15.79% |
| Q1 2025 Q2Q % growth | 49.324M 6,798.46% | 83.339M | -34.015M | -40.82% |
| Q4 2024 Q2Q % growth | 73.694M 15,189.21% | 73.841M | -147K | -0.20% |
| Q3 2024 Q2Q % growth | 58.555M 12,358.51% | 54.884M | 3.671M | 6.69% |
| Q2 2024 Q2Q % growth | 31.106M 12,860.83% | 25.08M | 6.026M | 24.03% |
| Q1 2024 Q2Q % growth | 715K | 2.117M | -1.402M | -66.23% |
| Q4 2023 Q2Q % growth | 482K | 1.419M | -937K | -66.03% |
| Q3 2023 Q2Q % growth | 470K | 4.276M | -3.806M | -89.01% |
| Q2 2023 Q2Q % growth | 240K | 3.655M | -3.415M | -93.43% |
| Q1 2023 Q2Q % growth | 204K | -204K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |